Navigation Links
Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
Date:5/7/2012

ix month period.

Balance SheetLandauer ended the second fiscal quarter of 2012 with total assets of $284.4 million, an increase of $115.7 million compared to total assets of $168.7 million at the end of fiscal 2011 due principally to the acquisition of IZI in November 2011.  The Company completed the quarter with $18.7 million of cash and cash equivalents on the balance sheet and unused borrowing capacity of $45.9 million under its current $175 million credit facility, which provides adequate liquidity to meet its current and anticipated obligations.  Adjusted Free Cash Flow provided by operating activities for the six months ended March 31, 2012 was $21.8 million, an increase of $2.2 million from the fiscal first half of 2012. The increase benefited from a tax refund during the first half of fiscal 2012, which was partially offset by an increase in capital expenditures.

Fiscal 2012 OutlookLandauer's business plan for fiscal 2012 currently anticipates aggregate revenues for the year to be in the range of $150 to $157 million, which includes 10 months of contributions from the recent IZI acquisition.  The business plan also anticipates:

  • $4.2 million ($2.8 million net of tax) of non-recurring expense spending to support the successful completion of the Company's IT Platform systems initiative and the related post implementation support.
  • Incremental depreciation and amortization over fiscal 2011 of $1.0 million ($0.7 million net of tax) related to the deployment of the final phase of the Company's IT systems initiative in the third quarter of fiscal 2012.
  • The accretive impact of the November 2011 acquisition of IZI is anticipated to produce $1.1 million to $1.5 million of net income for the 10 months included in fiscal 2012.
  • The blended effective tax rate for the full fiscal year is anticipated to be within a range of 31 percent to 33 percent.
  • Based upon the above assumptions, the Compan
    '/>"/>

    SOURCE Landauer, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Landauer, Inc. Declares Regular Cash Dividend
    2. Landauer, Inc. Reports Fiscal 2011 Fourth Quarter and Year End Results
    3. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2011 Results
    4. Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC
    5. Landauer, Inc. Reports Fiscal 2011 Third Quarter Results
    6. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2011 Results
    7. Landauer, Inc. Declares Regular Cash Dividend
    8. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2011 Results
    9. Landauer, Inc. Declares Regular Cash Dividend
    10. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results
    11. Landauer, Inc. Declares Regular Cash Dividend
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
    (Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
    (Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
    Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
    ... 9, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, May ... filed an amendment to regulate vaccines containing mercury in ... buy, sell, manufacture, deliver, import, administer or distribute any ... or inorganic mercury per milliliter for children younger than ...
    ... 2011 Kinex Pharmaceuticals, LLC announced today that Dr. Allen ... decided to step aside as CEO. Dr. ... from a start-up biotechnology company with only a technology platform ... pre-IND to phase 2 developments. The recent collaboration established with ...
    Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer 2The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer 3
    (Date:8/29/2014)... Angeles, CA (PRWEB) August 29, 2014 ... the expert knowledge and authenticity of its doctors. ... that only the most renowned doctors in their field ... helps to assure patients have a direct link to ... Patients and doctors will be able to communicate through ...
    (Date:8/29/2014)... Denver, Colorado (PRWEB) August 29, 2014 ... by Daily Gossip reveals that the new program ... , The method was created by a ... this method to overcome the disturbing problem. Manuel ... developing and using this system. , Learn ...
    (Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 DailyGossip.org ... This is an absolutely unique method of curing multiple ... new program was created by Dr. Gary M. Levin, ... health specialist started to become interested in alternative remedies ... that classical remedies cannot be effective in all cases ...
    (Date:8/29/2014)... CA (PRWEB) August 29, 2014 Dr. ... his plan to rename his practice to Parsa Mohebi ... Restoration has served the needs of hair loss patients ... traveled to its centers in Los Angeles, Beverly Hills, ... surgical and non surgical treatments, many of which Dr. ...
    (Date:8/29/2014)... (PRWEB) August 30, 2014 Developed as ... DoudouneCanadienneGoosePasCher.fr’s high quality Canada Goose products offer ... when working on Arctic runways. The company’s Canada ... jackets in the current market. Additionally, the firm has ... special offer. , At present, all high quality ...
    Breaking Medicine News(10 mins):Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:Nasal Polyps Treatment Miracle Review Exposes New Natural and Permanent Healing Program 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2Health News:US Hair Restoration Changes Name to Parsa Mohebi Hair Restoration to Better Reflect Founder 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2
    ... global food crisis that started in 2007, leading to ... are malnourished. The Institute of Medicine will convene ... implications of the food crisis on nutrition and health. ... crisis and escalating food prices on nutrition, country and ...
    ... , , VIRGINIA BEACH, Va., July 7 ... with Arthrex, Inc., has released the KinetiGraft Tendon, the ... new options for ligament and tendon reconstruction. , ... medicine physicians another alternative in repairing patient injuries. KinetiGraft ...
    ... July 7 Whole Foods Market (Nasdaq: ... announced a commitment to the Non-GMO Project - a ... breeders and consumers - to use the Non-GMO,s Product ... private label products. , , (Photo: ...
    ... WILTON, Conn., July 7 Startech Environmental Corp. (OTC BB: STHK), ... shareholders not to take any action with respect to the commencement ... Holdings LLC to purchase all of the outstanding shares of Startech ... board of directors today said that it will carefully review the ...
    ... Premier Research Group Limited, the international clinical research ... Data Capture Onsite 4.5.3, the enhanced version of Oracle,s ... of trial sponsors as well as investigative site personnel. ... tradition of Oracle Clinical data management as an early ...
    ... (FHC) (Nasdaq-CM: FHCO) today announced that Fortune has ... small companies in America. Fortune,s annual top-100 list rates ... their annualized revenue growth and their total return to investors. ... recognized the core strengths and growth potential of Female Health ...
    Cached Medicine News:Health News:LifeNet Health Launches Sports Medicine Bio-Implants 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 3Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 4Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 3Health News:Premier Research Launches Oracle(R) Remote Data Capture Onsite 4.5.3 2Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 2Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 3Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 4